Could the immune system hold the key to curing follicular lymphoma?
A world-first research group is investigating a new therapeutic approach.
- Non-Hodgkin lymphoma
- Research
A world-first research group is investigating a new therapeutic approach.
Kimberly Stegmaier's research focuses on finding new therapeutic targets for children with cancer.
Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.
Professor Gandhi discusses how personalised treatment is improving outcomes for people with Hodgkin lymphoma.
A protein critical for the survival of many cancer cells might be the key to a new treatment for lymphoma and leukaemia patients.
Professor Maher Gandhi talks about improving outcomes for patients with DLBCL.